<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36498091</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>23</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">16018</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph192316018</ELocationID><Abstract><AbstractText>The increasing number of people living with Long COVID requires the development of more personalized care; currently, limited treatment options and rehabilitation programs adapted to the variety of Long COVID presentations are available. Our objective was to design an easy-to-use Long COVID classification to help stratify people with Long COVID. Individual characteristics and a detailed set of 62 self-reported persisting symptoms together with quality of life indexes 12 months after initial COVID-19 infection were collected in a cohort of SARS-CoV-2 infected people in Luxembourg. A hierarchical ascendant classification (HAC) was used to identify clusters of people. We identified three patterns of Long COVID symptoms with a gradient in disease severity. Cluster-Mild encompassed almost 50% of the study population and was composed of participants with less severe initial infection, fewer comorbidities, and fewer persisting symptoms (mean = 2.9). Cluster-Moderate was characterized by a mean of 11 persisting symptoms and poor sleep and respiratory quality of life. Compared to the other clusters, Cluster-Severe was characterized by a higher proportion of women and smokers with a higher number of Long COVID symptoms, in particular vascular, urinary, and skin symptoms. Our study evidenced that Long COVID can be stratified into three subcategories in terms of severity. If replicated in other populations, this simple classification will help clinicians improve the care of people with Long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Aur&#xe9;lie</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2822-2874</Identifier><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badier</LastName><ForeName>Nolwenn</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6303-457X</Identifier><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7141-6730</Identifier><AffiliationInfo><Affiliation>Bioinformatics Platform, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elb&#xe9;ji</LastName><ForeName>Abir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilmes</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6478-2924</Identifier><AffiliationInfo><Affiliation>Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Campus Belval, L-4362 Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, L-4367 Belvaux, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oustric</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2004-4222</Identifier><AffiliationInfo><Affiliation>Association Apr&#xe8;s J20 COVID Long France, F-28110 Luc&#xe9;, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoy</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre Hospitalier Neuro-Psychiatrique, L-9002 Ettelbruck, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychiatric Hospital, University of Basel, 4002 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ollert</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8055-0103</Identifier><AffiliationInfo><Affiliation>Department of Infection and Immunity, Luxembourg Institute of Health, L-4354 Esch-sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), University of Southern Denmark, 5000 C Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagherazzi</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5033-5966</Identifier><AffiliationInfo><Affiliation>Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>14716273</GrantID><Agency>Luxembourg National Research Fund (FNR)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">clustering</Keyword><Keyword MajorTopicYN="N">disease severity</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36498091</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pii">ijerph192316018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering A.V., van Zon S.K.R., Hartman T.C.O., Rosmalen J.G.M., Lifelines Corona Research Initiative Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19): Post COVID-19 Condition.  [(accessed on 21 October 2022)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>World Health Organization  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.  [(accessed on 29 September 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., Hastie C., Roderick P., Yao G., Alwan N.A. Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect. Dis. 2020;7:ofaa509. doi: 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Zhang L., Elb&#xe9;ji A., Wilmes P., Oustric P., Staub T., Nazarov P.V., Ollert M., Fagherazzi G. Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infect. Dis. 2022;9:ofac397. doi: 10.1093/ofid/ofac397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Florencio L.L., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Torres-Macho J., Pellicer-Valero O.J. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2022:1&#x2013;9. doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O&#x2019;Brien C., Savinelli S., Tinago W., Yousif O., Lambert J.S., O&#x2019;Broin C., Feeney E.R., De Barra E., et al. Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect. Dis. 2022;9:ofac060. doi: 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagherazzi G., Fischer A., Betsou F., Vaillant M., Ernens I., Masi S., Mossong J., Staub T., Brault D., Bahlawane C., et al. Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: The Predi-COVID study. BMJ Open. 2020;10:e041834. doi: 10.1136/bmjopen-2020-041834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041834</ArticleId><ArticleId IdType="pmc">PMC7684799</ArticleId><ArticleId IdType="pubmed">33234656</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health (NIH)  COVID-19 Treatment Guidelines, Clinical Spectrum of SARS-CoV-2 Infection.  [(accessed on 2 March 2022)];2021  Available online:  https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Capelle C.M., Cir&#xe9; S., Domingues O., Ernens I., Hedin F., Fischer A., Snoeck C.J., Ammerlaan W., Konstantinou M., Grzyb K., et al. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients. Cell Rep. Med. 2022;3:100600. doi: 10.1016/j.xcrm.2022.100600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100600</ArticleId><ArticleId IdType="pmc">PMC8960124</ArticleId><ArticleId IdType="pubmed">35480624</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., III, Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninot G., Soyez F., Pr&#xe9;faut C. A short questionnaire for the assessment of quality of life in patients with chronic obstructive pulmonary disease: Psychometric properties of VQ11. Health Qual. Life Outcomes. 2013;11:179. doi: 10.1186/1477-7525-11-179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-11-179</ArticleId><ArticleId IdType="pmc">PMC3842624</ArticleId><ArticleId IdType="pubmed">24160852</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2020.  [(accessed on 30 October 2022)].  Available online:  https://www.R-project.org/</Citation></Reference><Reference><Citation>G&#xf3;mez-Rubio V. ggplot2&#x2014;Elegant Graphics for Data Analysis (2nd Edition) J. Stat. Softw. 2017;77:1&#x2013;3. doi: 10.18637/jss.v077.b02.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v077.b02</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J., Blau H., Bergquist T., Loomba J.J., Callahan T., Laraway B., Antonescu C., Casiraghi E., Coleman B., Gargano M., et al. Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs. medRxiv. 2022 doi: 10.1101/2022.05.24.22275398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.24.22275398</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S., Tsuzuki S., Suzuki M., Terada M., Akashi M., Osanai Y., Kuge C., Sanada M., Tanaka K., Maruki T., et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J. Infect Chemother. 2022;28:1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>